Adenovirus‐mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP‐C2 mouse prostate cancer model
- 20 February 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (8) , 831-838
Abstract
Background The interaction between CD40 ligand (CD40L) and CD40 on antigen presenting cells is essential for the initiation of antigen-specific T-cell responses, whereas CD40L stimulation of CD40+ tumor cells can induce cellular apoptosis. We investigated the anti-tumor effects induced by CD40L gene transfer into the mouse prostate adenocarcinoma cell line TRAMP-C2, both in vitro and in vivo. Methods TRAMP-C2 cells were transduced with an adenoviral vector encoding CD40L (AdCD40L). The induced expression of co-stimulatory molecules and cell viability was analyzed. AdCD40L-transduced TRAMP-C2 cells were used in prophylactic vaccination studies, while therapeutic studies were performed using peritumoral injections of AdCD40L. Results AdCD40L yielded reduced TRAMP-C2 cell viability and induced apoptosis in vitro. Vaccination with CD40L-expressing TRAMP-C2 cells induced anti-tumor immunity and peritumoral AdCD40L injections induced tumor growth suppression. Conclusions Our observations highlight the therapeutic potential of using AdCD40L as a monotherapy or in combination with conventional chemotherapy or novel therapies (e.g., oncolytic viruses). The use of AdCD40L offers an attractive option for future clinical trials. ProstateKeywords
This publication has 21 references indexed in Scilit:
- Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinomaThe Prostate, 2007
- The Immunobiology of Cancer Immunosurveillance and ImmunoeditingImmunity, 2004
- CD40/CD154 Interactions at the Interface of Tolerance and ImmunityAnnual Review of Immunology, 2004
- NaturallyArisingCD4+RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponsesAnnual Review of Immunology, 2004
- Antitumor immunity against bladder cancer induced by ex vivo expression of CD40 ligand gene using retrovirus vectorCancer Gene Therapy, 2003
- Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancerCancer Immunology, Immunotherapy, 2003
- Prospects for CD40-directed experimental therapy of human cancerCancer Gene Therapy, 2002
- The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic CellsJournal of Experimental Medicine, 2000
- Dendritic Cells Infiltrating Tumors Cotransduced with Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf) and Cd40 Ligand Genes Take up and Present Endogenous Tumor-Associated Antigens, and Prime Naive Mice for a Cytotoxic T Lymphocyte ResponseJournal of Experimental Medicine, 1999
- Anti-Tumor Immunity Induced by in Vivo Adenovirus Vector-Mediated Expression of CD40 Ligand in Tumor CellsHuman Gene Therapy, 1999